Comparison of Maitland Oscillatory Mobilizations With Kaltenborn Sustained Stretch Mobilizations in Cervicogenic Headache Patients
Launched by FOUNDATION UNIVERSITY ISLAMABAD · Mar 9, 2023
Trial Information
Current as of July 05, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-45 years
- • Both males and females
- • Unilateral headache with no shift of side
- • C1-C2 dysfunction
- • Headache with neck stiffness
- • Headache at least once a month in the last 3 months
- • Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
- • Headache with a score of at least 4 in the Numeric pain rating scale
- Exclusion Criteria:
- • Cervical spondylosis
- • Headache of non-cervical origin
- • Dizziness or visual disturbance
- • Cervical radiculopathy/ nerve root involvement/ disc herniation
- • Cervical instability/ fracture
- • Vertebrobasilar insufficiency
- • Thoracic outlet syndrome
- • Cervical spine surgery
- • Cervical spondylolisthesis
- • Spinal infection or tumors
- • Osteoporosis
- • History of trauma
- • Metabolic disorders
- • Rheumatoid Arthritis
- • Inflammatory Arthritis
About Foundation University Islamabad
Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials